Digoxin Tablets, USP 62.5 mcg (0.0625 mg), 100-count bottles, Rx Only, Manufactured by: Novitium Pharma LLC, 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-200-10
Published April 24, 2024 · Recall initiated: March 25, 2024
Summary
FDA records drug Class III recall D-0443-2024, published April 24, 2024 and initiated March 25, 2024. Recalling firm: Novitium Pharma LLC; Status: Terminated; Reported quantity: 1,003 bottles; Lot: Lot M23011A; Exp. 12/2024. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email if DIGOXIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DIGOXIN
- Manufacturer
- Novitium Pharma LLC
- Distributor
- U.S. Nationwide
- UPC
- 0370954201106
- Lot
- Lot M23011A; Exp. 12/2024
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAVancomycin Hydrochloride for Oral Solution, USP, 250 mg per 5 mL, packaged as (a) 80 mL bottle, NDCApril 24, 2024
- FDAAtovaquone Oral Suspension USP, 750 mg per 5 mL sachets, 20 Units x 5 mL cartons, Rx Only, Manufactured for:April 24, 2024
- FDANEXLIZET (bempedoic acid and ezetimibe) tablets, 180 mg/10 mg, 30-count bottle, Rx only, Manufactured for:April 24, 2024
- FDASterile Diluent, HUMALOG U-100 (insulin lispro injection), HUMULIN R U-100 REGULAR (insulin human injection),April 24, 2024
- FDAPatient Cart, Part: 380601, a component of the da Vinci SP Surgical System, Model: SP1098April 17, 2024
- FDADigoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70March 27, 2024
Questions about this recall
Was Digoxin Tablets, USP 62.5 mcg (0.0625 mg), 100-count bottles, Rx Only, Manufactured by: Novitium Pharma LLC, 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-200-10 recalled?
Yes. FDA published recall D-0443-2024 on April 24, 2024. Reported hazard: Failed Impurities/Degradation Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DIGOXIN. UPC: 0370954201106.